Aliviar

Data Snapshot: Sep 06, 2024
Aliviar Cannabis Brand Logo
<$50K

Aug-2024

Sales

Growth

Trend

6-Month

7

Product Count

SKUs

Aliviar

Overview

Aliviar is a medical cannabis brand, developed by MedPharm, renowned for its CBD-rich formulation that offers a 20:1 CBD to THC ratio, which primarily serves patients seeking to alleviate chemotherapy-induced nausea and other ailments without the psychoactive effects of THC. As part of the Bud & Mary's family of lifestyle and medical cannabis brands, Aliviar is a reputable name in the cannabis industry, prioritizing research and product development. Notably, this brand is often sought after in Colorado for delivering natural, rapid-action solutions via its conscientiously developed products.
Markets

Aliviar Locations

Product Trends

Aliviar Categories

Aliviar Sales

Market Insights Snapshot

Aliviar Historical Sales by Category

Aliviar has shown consistent performance in the Colorado market, particularly in the Tincture & Sublingual category. From May to August 2024, Aliviar maintained a stable rank, starting at 3rd place in May and holding the 4th position from June through August. This stability suggests a strong and loyal customer base for their tincture products. However, it should be noted that despite a drop in sales from May to June, there was a significant rebound in July, indicating potential seasonal demand or successful promotional efforts. On the other hand, in the Topical category, Aliviar only appeared in the rankings in August, securing the 10th position, which could indicate either a recent entry into this category or fluctuating market presence.

While Aliviar's presence in the Tincture & Sublingual category in Colorado is commendable, their absence from the top 30 brands in the Topical category for the months of May, June, and July is noteworthy. This absence could be seen as a missed opportunity or an area for growth, especially considering their eventual entry into the top 10 in August. The brand's ability to break into the rankings in August suggests potential for growth if they can maintain or improve their position. Overall, Aliviar's performance in Colorado reflects both strengths in established categories and opportunities for expansion in others.

Aug-2024 Rank
Tincture & Sublingual
Topical
4
Aliviar

Competitive Landscape

In the competitive landscape of Colorado's Tincture & Sublingual category, Aliviar has demonstrated consistent performance, maintaining a stable rank of 4th place from June to August 2024. Despite a slight dip in sales from May to June, Aliviar saw a significant rebound in July, with sales peaking at 41,826 units before settling at 36,600 units in August. This stability in rank is notable given the dynamic shifts among competitors. For instance, Care Division surged from 5th to 3rd place in June, maintaining that position through August with sales consistently outperforming Aliviar. Meanwhile, Escape Artists held steady at 5th place, trailing closely behind Aliviar in sales. The top spot was dominated by My Brother's Flower, which only slipped to 2nd place in August. These insights suggest that while Aliviar is a strong contender, there is fierce competition, particularly from brands like Care Division and My Brother's Flower, which could impact Aliviar's market share and necessitate strategic adjustments to maintain or improve its position.

Aliviar market ranking for CO Tincture & Sublingual

Aliviar

Notable Products

In August 2024, the top-performing product for Aliviar was CBD/THC 20:1 Calm Tincture (1400mg CBD, 70mg THC) in the Tincture & Sublingual category, maintaining its first-place ranking with sales of 1106 units. The CBD/THC/CBN 5:1:1 Sleep Tincture (250mg CBD, 50mg THC, 50mg CBN, 10ml) also held steady in second place. The CBD/THC 2:1 Unscented Cream (650mg CBD, 325mg THC, 2oz) improved its position to third place from fourth in the previous three months. Conversely, the CBD/THC 2:1 Scented Cream (420mg CBD, 210mg THC, 2oz) dropped to fourth place from third. Finally, the CBD/THC 2:1 Sport Cream (420mg CBD, 210mg THC, 2oz) remained in fifth place, consistent with its ranking in May and June but having briefly climbed to fourth in July.

Product Rank
Category
May-2024
Jun-2024
Jul-2024
Aug-2024
CBD/THC 20:1 Calm Tincture (1400mg CBD, 70mg THC)
Tincture & Sublingual
1
1
1
1
CBD/THC/CBN 5:1:1 Sleep Tincture (250mg CBD, 50mg THC, 50mg CBN, 10ml)
Tincture & Sublingual
2
2
2
2
CBD/THC 2:1 Unscented Cream (650mg CBD, 325mg THC, 2oz)
Topical
4
4
4
3
CBD/THC 2:1 Scented Cream (420mg CBD, 210mg THC, 2oz)
Topical
3
3
3
4
CBD/THC 2:1 Sport Cream (420mg CBD, 210mg THC,2oz)
Topical
5
5
4
5
View product & sales data

Top Selling Cannabis Brands

Simple, transparent pricing that grows with you. Try any plan free for 30 days.
Research the top cannabis brands across markets in the US and Canada.

Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.

Header image
User rating
start Today
Connect to Headset

Get Cannabis Market Data